The fate of low grade dysplasia in ulcerative colitis

Ullman, Thomas A.; Loftus Jr, Edward V.; Kakar, Sanjay; Burgart, Lawrence J.; Sandborn, William J.; Tremaine, William J.
April 2002
American Journal of Gastroenterology;Apr2002, Vol. 97 Issue 4, p922
Academic Journal
OBJECTIVE:The optimal strategy for the management of definite low grade dysplasia (LGD) detected in surveillance in ulcerative colitis (UC) is unknown, because the natural history of LGD has not been well described.METHODS:We reviewed the Mayo Clinic records of patients with UC found to have flat LGD between 1990 and 1993 in whom a nonoperative strategy was pursued for 2 months or more.RESULTS:Eighteen patients with UC and LGD were observed for a median of 32 months. Nine of 18 patients identified with UC and LGD developed advanced neoplastic lesions during follow-up, which were defined as adenocarcinoma, raised dysplasia, or high grade dysplasia. The cumulative incidence of progression to an advanced lesion was 33% at 5 yr (95% CI = 9–56%). Only one patient developed adenocarcinoma, diagnosed 74 months after his initial finding of LGD and 20 months after his last surveillance exam. Besides this patient, adenocarcinoma was not detected in the colectomy specimens of 13 other patients who underwent surgery. Colectomies were performed for dysplasia or cancer in seven patients, active colitis in five patients, and unknown reasons in two patients. Four patients did not have colectomies.CONCLUSIONS:Neoplastic progression in patients with UC and LGD is common. Total proctocolectomy should be offered to all patients with flat LGD. Our study illustrates numerous pitfalls in the practice of surveillance.


Related Articles

  • Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Brentnall, T. A. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p116 

    A review of the article "Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines," by T. L. Zisman and colleagues, which appeared in the periodical "Digestive Diseases and Sciences" on January 11, 2013 is presented.

  • DYSPLASIA IN ULCERATIVE COLITIS IS USUALLY VISIBLE AT COLONOSCOPY. Rutter, M.D.; Wilkinson, K.H.; Saunders, B.P. // Gut;Apr2003 Supplement 1, Vol. 52, pA4 

    Background and Aim: During colonoscopic surveillance for dysplasia in longstanding extensive ulcerative colitis (UC), multiple non-targeted "random" biopsies of colonic mucosa are advised, based on historical data suggesting dysplasia may only be detectable microscopically. We aimed to assess...

  • Telomere shortening in the colonic mucosa of patients with ulcerative colitis. Kinouchi, Yoshitaka; Hiwatashi, Nobuo; Chida, Masaki; Nagashima, Fumio; Takagi, Sho; Maekawa, Hiroki; Toyota, Takayoshi // Journal of Gastroenterology;1998, Vol. 33 Issue 3, p343 

    Abstract: Telomere length in human somatic cells gradually decreases with the number of cell divisions and is regarded as a marker of somatic cell turnover. Mucosal cells of the affected colon show rapid turnover in individuals with active ulcerative colitis (UC). Telomere length was determined...

  • THE RISK OF DYSPLASIA IN POST-SURGICAL COLORECTAL MUCOSA IN ULCERATIVE COLITIS. Rutter, M.D.; Saunders, B.P. // Gut;Apr2003 Supplement 1, Vol. 52, pA95 

    Background and Aim: Although panproctocolectomy (PPC) is the operation of choice in longstanding extensive ulcerative colitis (UC), other procedures are occasionally chosen, leaving the patient at risk of dysplasia/cancer in the colorectal remnant. We aimed to assess this risk. Methods:...

  • Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity. D Awais // Gut;Nov2009, Vol. 58 Issue 11, p1498 

    BACKGROUND: Endoscopic surveillance of chronic colitis uses random biopsies to find dysplastic fields. Enhanced endoscopic methods are more sensitive for dysplasia detection, but their specificity for colorectal cancer risk is unknown. AIMS: To develop a mathematical model of the sensitivity of...

  • The Risk of Cancer and Dysplasia among Ulcerative Colitis Patients with Primary Sclerosing Cholangitis. Marchesa, Pierenrico; Lashner, Bret A.; Lavery, Ian C.; Milsom, Jeffrey; Hull, Tracy L.; Strong, Scott A.; Church, James M.; Navarro, Georgia; Fazio, Victor W. // American Journal of Gastroenterology;Aug1997, Vol. 92 Issue 8, p1285 

    Background: Ulcerative colitis (UC) patients with primary sclerosing cholangitis (PSC) may have an increased risk for colonic dysplasia or cancer. They also may have higher levels of carcinogenic secondary bile acids and, thus, be more likely to develop cancer in the right side of the colon,...

  • Conservative Management of Small Adenomata in Ulcerative Colitis. Medlicott, S. A. C.; Jewell, L. D.; Price, L.; Fedorak, R. N.; Sherbaniuk, R. W.; Urbanski, S. J. // American Journal of Gastroenterology;Nov1997, Vol. 92 Issue 11, p2094 

    Objective and Methods: Patients with chronic ulcerative colitis may develop colitis-related dysplasia and/or sporadic adenomata. Differentiating between these two processes is important because they may dictate different therapeutic approaches. Although distinguishing features of sporadic...

  • Physicians' Perceptions of Dysplasia and Approaches to Surveillance Colonoscopy in Ulcerative Colitis. Bernstein, Charles N.; Weinstein, Wilfred M.; Levine, Douglas S.; Shanahan, Fergus // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2106 

    Objective: Colonoscopic biopsy surveillance to detect dysplasia, defined as a neoplastic change of the epithelium without invasion into the lamina propria, in patients with ulcerative colitis has become a widespread practice. We undertook a survey study to determine physicians' perceptions of,...

  • Delayed Perforation of the Cecum after Diagnostic Biopsy. Loggan, Michael; Moeller, Donald D. // American Journal of Gastroenterology;Dec1984, Vol. 79 Issue 12, p933 

    Colonoscopy is an important diagnostic study in monitoring patients with chronic ulcerative colitis for carcinoma and dysplasia (precancer). A 76-year-old woman with chronic ulcerative colitis of 13 years' duration underwent colonoscopy. Biopsies were obtained at 10-cm intervals throughout the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics